DI NISIO, Marcello
 Distribuzione geografica
Continente #
NA - Nord America 8.281
AS - Asia 5.441
EU - Europa 4.436
SA - Sud America 814
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 12
Totale 19.098
Nazione #
US - Stati Uniti d'America 8.106
SG - Singapore 2.490
CN - Cina 1.364
IE - Irlanda 776
RU - Federazione Russa 675
BR - Brasile 671
UA - Ucraina 623
VN - Vietnam 543
SE - Svezia 534
IT - Italia 528
TR - Turchia 428
GB - Regno Unito 362
DE - Germania 300
FR - Francia 210
FI - Finlandia 178
IN - India 144
HK - Hong Kong 115
CA - Canada 82
BD - Bangladesh 70
AR - Argentina 65
MX - Messico 55
AT - Austria 46
ES - Italia 45
JP - Giappone 38
NL - Olanda 38
PL - Polonia 36
IQ - Iraq 34
ZA - Sudafrica 31
BE - Belgio 25
ID - Indonesia 25
EC - Ecuador 23
TW - Taiwan 23
PK - Pakistan 19
CO - Colombia 16
CZ - Repubblica Ceca 15
KR - Corea 14
JM - Giamaica 13
JO - Giordania 13
MA - Marocco 13
EU - Europa 12
PH - Filippine 12
SA - Arabia Saudita 12
UZ - Uzbekistan 12
AU - Australia 11
EG - Egitto 11
IL - Israele 11
KE - Kenya 11
PY - Paraguay 9
TN - Tunisia 9
VE - Venezuela 9
LT - Lituania 8
AZ - Azerbaigian 7
IR - Iran 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
MY - Malesia 6
RO - Romania 6
CL - Cile 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
LB - Libano 5
PE - Perù 5
QA - Qatar 5
UY - Uruguay 5
DZ - Algeria 4
HN - Honduras 4
KG - Kirghizistan 4
OM - Oman 4
PS - Palestinian Territory 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
CH - Svizzera 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
GA - Gabon 3
GT - Guatemala 3
HR - Croazia 3
KZ - Kazakistan 3
NO - Norvegia 3
SR - Suriname 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
GR - Grecia 2
HU - Ungheria 2
KW - Kuwait 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
SC - Seychelles 2
SN - Senegal 2
SV - El Salvador 2
TL - Timor Orientale 2
AI - Anguilla 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
DM - Dominica 1
Totale 19.077
Città #
Singapore 1.768
Chandler 1.002
San Jose 897
Jacksonville 865
Dublin 764
Ashburn 609
Princeton 393
Dallas 381
Beijing 318
Izmir 271
Nanjing 216
Los Angeles 202
Ho Chi Minh City 196
Santa Clara 194
Altamura 184
Southend 177
Wilmington 169
Cambridge 137
Council Bluffs 132
Dearborn 132
The Dalles 118
Hanoi 107
Hong Kong 106
Boardman 93
Ann Arbor 83
Houston 81
Buffalo 80
New York 77
Tongling 76
São Paulo 74
Nanchang 71
Woodbridge 68
Helsinki 62
Chieti 61
Redondo Beach 61
Moscow 53
Munich 50
Kunming 47
Hebei 46
Orem 41
Seattle 39
Shenyang 36
Tianjin 36
Washington 36
Jiaxing 34
Tokyo 34
Warsaw 33
Dong Ket 31
Vienna 29
Chicago 28
Hefei 28
Montreal 28
Nuremberg 28
Brooklyn 26
Haiphong 26
Pescara 26
Changsha 25
Denver 25
Chennai 24
Poplar 24
Atlanta 23
Brussels 23
Frankfurt am Main 22
London 22
Norwalk 22
Phoenix 21
St Louis 21
Baghdad 19
Da Nang 19
Guangzhou 19
Johannesburg 19
Rio de Janeiro 19
San Francisco 19
Boston 18
Hangzhou 18
Manchester 18
Milan 18
Amsterdam 17
Rome 17
Mexico City 16
Stockholm 16
Shanghai 15
Fairfield 14
Pune 14
Amman 13
Biên Hòa 13
Falls Church 13
Leawood 13
Mumbai 13
Toronto 13
Ankara 12
Brasília 12
Dhaka 12
Taipei 12
Turku 12
Grevenbroich 11
Guayaquil 11
Olomouc 11
Porto Alegre 11
Belo Horizonte 10
Totale 11.699
Nome #
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 243
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 173
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 170
Supportive management strategies for disseminated intravascular coagulation: An international consensus 166
24 weeks of Pilates-aerobic and educative training to improve body fat mass in elderly Serbian women 161
Circulating leptin is associated with oxidized LDL in postmenopausal women. 141
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 133
Treatment of Lower Extremity Superficial Thrombophlebitis 133
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 131
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 131
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 129
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 129
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC 127
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 127
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 125
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 125
Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity 124
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 124
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer 123
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 122
Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation 122
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 121
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 121
Non-O blood group and outcomes of in vitro fertilization 121
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis 121
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 120
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 119
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world: Actual use of low-molecular-weight heparin in cancer 119
Edoxaban for the treatment of cancer-associated venous thromboembolism 118
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 117
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 117
Low-molecular-weight heparin for the treatment of acute venous thromboembolism in patients with active cancer 116
Computerised cognitive training for preventing dementia in people with mild cognitive impairment 116
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 115
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 115
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 115
Whole-Arm ultrasound for suspected upper-extremity deep venous thrombosis in outpatients 114
Effects of body composition on the procoagulant imbalance in obese patients 114
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 114
A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients 113
Deep vein thrombosis and pulmonary embolism 112
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 112
Rivaroxaban for cancer-associated cardiac thrombosis 111
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia 111
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 109
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis 109
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation 109
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis 108
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH 108
Improving the diagnostic management of upper extremity deep vein thrombosis 108
Edoxaban for treatment of venous thromboembolism in patients with cancer: Rationale and design of the hokusai VTE-cancer study 108
Safety and efficacy of low-dose fondaparinux (1.5mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The FONDAIR study 108
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 107
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis 107
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation 107
Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry 107
The hematocrit and platelet target in polycytemia vera 106
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 106
Use of heparins in patients with cancer: Individual participant data metaanalysis of randomised trials study protocol 106
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 106
Antithrombotic therapy and cancer 105
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 104
The diagnostic management of upper extremity deep vein thrombosis: A review of the literature 104
A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism 104
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis 104
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife 103
Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone 102
Cannabinoids for medical use: A systematic review and meta-analysis 101
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer 101
Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants 100
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists 100
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 100
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts 100
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 100
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study 99
Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots 98
Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients 98
Treatment for superficial infusion thrombophlebitis of the upper extremity. 97
Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants 97
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis 97
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life 97
Cancer-associated unsuspected pulmonary embolism 97
Splanchnic vein thrombosis: Current perspectives 97
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis 96
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis 96
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 96
D-Dimer test in cancer patients with suspected acute pulmonary embolism 96
D-Dimer Test In Cancer Patients With Suspected Acute Pulmonary Embolism 95
Effects of Obesity and Thrombophilia on the Risk of Abortion in Women Undergoing In Vitro Fertilization 95
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving high dose chemotherapy for hematological malignancies, a randomized placebo controlled study 94
Obesity, Poor Muscle Strength and the Risk of Venous Thromboembolism in Older Persons: the InCHIANTI Study 94
Safety and feasibility of diagnostic algorithm combining clinical probability, D-dimer and ultrasonography in suspected upper extremity deep vein thrombosis: a prospective management study. 94
Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study 94
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life 94
Anticoagulant treatment for upper extremity deep vein thrombosis: A systematic review and meta-analysis 94
Inhaled analgesia for pain management in labour 94
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis 93
High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis 93
Decision analysis for cancer screening in idiopathic venous thromboembolism 93
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome 93
Totale 11.259
Categoria #
all - tutte 88.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022758 10 10 9 116 35 27 31 65 53 22 107 273
2022/20232.957 249 388 133 308 328 586 156 227 384 43 95 60
2023/20241.286 98 45 141 48 106 373 254 49 27 39 5 101
2024/20252.995 200 619 402 63 52 98 76 250 345 130 353 407
2025/20267.009 506 273 772 855 718 403 1.128 484 813 670 300 87
2026/202793 93 0 0 0 0 0 0 0 0 0 0 0
Totale 19.836